Insider share sales at Phathom Pharmaceuticals in the last t...
Insider share sales at Phathom Pharmaceuticals in the last three months are not substantial but still concerning. The level of insider ownership shows some alignment with smaller shareholders. However, 6 warning signs, 3 of which are concerning, should be noted by investors.
Phathom Pharmaceuticals Insider Confidence Rewarded, Stock Hits US$532m Market Cap
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment